Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis

Bioanalysis

Volumn 6, Issue 6, 2014, Pages 843-857

  Davies, Simon J ^a,b   Španěl, Patrik ^a,c   Smith, David ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; DEUTERIUM; ETHANE; ISOPRENE; PENTANE; VOLATILE ORGANIC COMPOUND;

ABSORPTION SPECTROSCOPY; BIOCOMPATIBILITY; BREATH ANALYSIS; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; HYDRATION; ION MOBILITY SPECTROMETRY; LIMIT OF DETECTION; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PERITONEAL DIALYSIS; PROTEIN INTAKE; PROTEIN METABOLISM; REVIEW; SOLID PHASE MICROEXTRACTION; TOTAL BODY WATER; WATER VAPOR; CHRONIC KIDNEY FAILURE; METABOLISM; PROCEDURES; RENAL REPLACEMENT THERAPY;

AMMONIA; BREATH TESTS; HUMANS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; VOLATILE ORGANIC COMPOUNDS;

EID: 84898758129     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.26     Document Type: Review

References (113)

1. Larsson BT. Gas chromatography of organic volatiles in human breath and saliva. Acta Chem. Scand. 19(1), 159-164 (1965).
2. Richter VJ, Tonzetich J. The application of instrumental technique for the evaluation of odoriferous volatiles from saliva and breath. Arch. Oral Biol. 9(1), 47-53 (1964).
3. Teranish R, Robinson AB, Cary P, Mon TR, Pauling L. Gas-chromatography of volatiles from breath and urine. Anal. Chem. 44(1), 18-20 (1972).
4. Manolis A. The diagnostic potential of breath analysis. Clin. Chem. 29(1), 5-15 (1983).
5. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B 729(1-2), 75-88 (1999).
6. Phillips M, Greenberg J, Sabas M. Alveolar gradient of pentane in normal human breath. Free Radic. Res. 20(5), 333-337 (1994).
7. Phillips M, Sabas M, Greenberg J. Increased pentane and carbon-disulfide in the breath of patients with schizophrenia. J. Clin. Pathol. 46(9), 861-864 (1993).
8. Amann A, Smith D. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. World Scientific, Singapore (2005).
9. Amann A, Smith D. Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine. Elsevier, Amsterdam, the Netherlands (2013).
10. Španěl P, Smith D. Advances in on-line absolute trace gas analysis by SIFT-MS. Curr. Anal. Chem. 9(4), 525-539 (2013).
11. Smith D, Španěl P. On the features, successes and challenges of selected ion flow tube mass spectrometry, SIFT-MS. Eur. J. Mass Spectrom. 19(4), 225-246 (2013).
12. Španěl P, Smith D. Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom. Rev. 30(2), 236-267 (2011).
13. Španěl P, Smith D. Selected ion flow tube-mass spectrometry: detection and real-time monitoring of flavours released by food products. Rapid Commun. Mass Spectrom. 13(7), 585-596 (1999).
14. Zhan XF, Duan JN, Duan YX. Recent developments of proton-transfer reaction mass spectrometry (PTR-MS) and its applications in medical research. Mass Spectrom. Rev. 32(2), 143-165 (2013).
15. Hartungen E, Jurschik S, Jordan A et al. Proton transfer reaction-mass spectrometry: fundamentals, recent advances and applications. Eur. Phys. J. Appl. Phys. 61(2), 24303 (2013).
16. Smith D, Španěl P. Direct, rapid quantitative analyses of BVOCs using SIFT-MS and PTR-MS obviating sample collection. Trends Analyt. Chem. 30(7), 945-959 (2011).
17. Hansel A, Jordan A, Holzinger R, Prazeller P, Vogel W, Lindinger W. Proton-transfer reaction mass-spectrometry - online trace gas-analysis at the ppb level. Int. J. Mass Spectrom. Ion Process. 149(150), 609-619 (1995).
18. Davies S, Španěl P, Smith D. A new 'online' method to measure increased exhaled isoprene in end-stage renal failure. Nephrol. Dial. Transplant. 16(4), 836-839 (2001).
19. Smith D, Davies S, Španěl P. SIFT-MS analysis of breath isoprene: a marker of treatment stress in haemodialysis patients? FASEB J. 14(4), A573-A573 (2000).
20. Španěl P, Davies S, Smith D. Quantification of breath isoprene using the selected ion flow tube mass spectrometric analytical method. Rapid Commun. Mass Spectrom. 13(17), 1733-1738 (1999).
21. Španěl P, Davies S, Smith D. Quantification of ammonia in human breath by the selected ion flow tube analytical method using H3O+ and O2+ precursor ions. Rapid Commun. Mass Spectrom. 12(12), 763-766 (1998).
22. Davies S, Španěl P, Smith D. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. Kidney Int. 52(1), 223-228 (1997).
23. Davies SJ, Španěl P, Smith D. Quantitative analysis of metabolites on the breath of patients in renal failure. J. Am. Soc. Nephrol. 7(9), A0352-A0352 (1996).
24. Robergs RA, Dwyer D, Astorino T. Recommendations for improved data processing from expired gas analysis indirect calorimetry. Sports Med. 40(2), 95-111 (2010).
25. Španěl P, Smith D. On-line measurement of the absolute humidity of air, breath and liquid headspace samples by selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom. 15(8), 563-569 (2001).
26. Solga SF, Mudalel M, Spacek LA et al. Factors influencing breath ammonia determination. J. Breath Res. 7(3), 037101 (2013).
27. Sinues PML, Kohler M, Zenobi R. Monitoring diurnal changes in exhaled human breath. Anal. Chem. 85(1), 369-373 (2013).
28. Smith D, Španěl P, Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. J. Appl. Physiol. 87(5), 1584-1588 (1999).
29. Španěl P, Davies S, Smith D. Breath ammonia dips after feeding independently of the protein content of the meal. FASEB J. 14(4), A490-A490 (2000).
30. Smith D, Turner C, Španěl P. Volatile metabolites in the exhaled breath of healthy volunteers: their levels and distributions. J. Breath Res. 1(1), 014004 (2007).
31. Španěl P, Turner C, Wang TS, Bloor R, Smith D. Generation of volatile compounds on mouth exposure to urea and sucrose: implications for exhaled breath analysis. Physiol. Meas. 27(2), N7-N17 (2006).
32. Khalid TY, Saad S, Greenman J, Costello BD, Probert CSJ, Ratcliffe NM. Volatiles from oral anaerobes confounding breath biomarker discovery. J. Breath Res. 7(1), 017114 (2013).
33. Wang TS, Pysanenko A, Dryahina K, Španěl P, Smith D. Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J. Breath Res. 2(3), 037013 (2008).
34. Smith D, Wang TS, Pysanenko A, Španěl P. A selected ion flow tube mass spectrometry study of ammonia in mouth- and nose-exhaled breath and in the oral cavity. Rapid Commun. Mass Spectrom. 22(6), 783-789 (2008).
35. Hibbard T, Killard AJ. Breath ammonia analysis: clinical application and measurement. Crit. Rev. Anal. Chem. 41(1), 21-35 (2011).
36. Wang JW, Xie H, Liang LR, Zhang W, Peng W, Yu QX. Tunable fiber laser based photoacoustic spectrometer for breath ammonia analysis during hemodialysis1. Laser Phys. 22(1), 327-330 (2012).
37. Schmidt FM, Vaittinen O, Metsala M et al. Ammonia in breath and emitted from skin. J. Breath Res. 7(1), 017109 (2013).
38. Neri G, Lacquaniti A, Rizzo G, Donato N, Latino M, Buemi M. Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques. Nephrol. Dial. Transplant. 27(7), 2945-2952 (2012).
39. Wang J, Zhang W, Li L, Yu Q. Breath ammonia detection based on tunable fiber laser photoacoustic spectroscopy. Appl. Phys. B Lasers Opt. 103(2), 263-269 (2011).
40. Hibbard T, Killard AJ. Breath ammonia levels in a normal human population study as determined by photoacoustic laser spectroscopy. J. Breath Res. 5(3), 037101 (2011).
41. Hibbard T, Crowley K, Killard AJ. Direct measurement of ammonia in simulated human breath using an inkjet-printed polyaniline nanoparticle sensor. Anal. Chim. Acta 779, 56-63 (2013).
42. Dai MZ, Lin YL, Lin HC et al. Detecting breath ammonia for non-invasive diagnostic based on low-cost organic diode with vertical nanojunctions. In: 2012 IEEE Sensors Proceedings. IEEE, NY, USA, 908-911 (2012).
43. Gouma P, Kalyanasundaram K, Yun X, Stanacevic M, Wang LS. Nanosensor and breath analyzer for ammonia detection in exhaled human breath. IEEE Sens. J. 10(1), 49-53 (2010).
44. Turner C, Španěl P, Smith D. A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol. Meas. 27(4), 321-337 (2006).
45. Ajibola OA, Smith D, Španěl P, Ferns GAA. Effects of dietary nutrients on volatile breath metabolites. J. Nutr. Sci. 2, e34 (2013).
46. Pysanenko A, Španěl P, Smith D. A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry. J. Breath Res. 2(4), 046004 (2008).
47. Han KH, Mekala K, Babida V et al. Expression of the gas-transporting proteins, Rh B glycoprotein and Rh C glycoprotein, in the murine lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 297(1), L153-L163 (2009).
48. Narasimhan LR, Goodman W, Patel CKN. Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc. Natl Acad. Sci. USA 98(8), 4617-4621 (2001).
49. Eknoyan G, Kopple J, Levey A et al. Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int. 52(5), 1395-1405 (1997).
50. Endre ZH, Pickering JW, Storer MK et al. Breath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy. Physiol. Meas. 32(1), 115-130 (2011).
51. Jazan E, Mirzaei H. Direct analysis of human breath ammonia using corona discharge ion mobility spectrometry. J. Pharm. Biomed. Anal. 88, 315-320 (2014).
52. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile of uremic breath. New Engl. J. Med. 297(3), 132-135 (1977).
53. Smith D, Španěl P: The novel selected-ion flow tube approach to trace gas analysis of air and breath. Rapid Commun. Mass Spectrom. 10(10), 1183-1198 (1996).
54. Bain MA, Faull R, Fornasini G, Milne RW, Evans AM. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol. Dial. Transplant. 21(5), 1300-1304 (2006).
55. Grabowska-Polanowska B, Faber J, Skowron M et al. Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method. J. Chromatogr. A 1301, 179-189 (2013).
56. Pagonas N, Vautz W, Seifert L et al. Volatile organic compounds in uremia. PLoS ONE 7(9), e46258 (2012).
57. Kohl I, Beauchamp J, Cakar-Beck F et al. First observation of a potential non-invasive breath gas biomarker for kidney function. J. Breath Res. 7(1), 017110 (2013).
58. Španěl P, Ji YF, Smith D. SIFT studies of the reactions of H3O+, NO+ and O2+ with a series of aldehydes and ketones. Int. J. Mass Spectrom. 165, 25-37 (1997).
59. Fairley DA, Milligan DB, Freeman CG, Mcewan MJ, Španěl P, Smith D. Competitive association and charge transfer in the reactions of NO+ with some ketones: a selected ion flow drift tube study. Int. J. Mass Spectrom. 193(1), 35-43 (1999).
60. Smith S, Burden H, Persad R et al. A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry. J. Breath Res. 2(3), 037022 (2008).
61. Wahl HG, Hong Q, Hildenbrand S, Risler T, Luft D, Liebich H. 4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol. Dial. Transplant. 19(10), 2576-2583 (2004).
62. Zhou Y, Wang H, Chen Y, Jiang Q. Environmental and food contamination with plasticisers in China. Lancet 378(9803), e4 (2011).
63. Erhart S, Amann A, Haberlandt E et al. 3-Heptanone as a potential new marker for valproic acid therapy. J. Breath Res. 3(1), 016004 (2009).
64. Haick H, Hakim M, Patrascu M et al. Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano 3(5), 1258-1266 (2009).
65. Moorhead KT, Hill JV, Chase JG et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput. Methods Programs Biomed. 101(2), 173-182 (2011).
66. Meinardi S, Jin KB, Barletta B, Blake DR, Vaziri ND. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease. Biochim. Biophys.Acta 1830(3), 2531-2537 (2013).
67. Marom O, Nakhoul F, Tisch U, Shiban A, Abassi Z, Haick H. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine 7(5), 639-650 (2012).
68. Voss A, Baier V, Reisch R et al. Smelling renal dysfunction via electronic nose. Ann. Biomed. Eng. 33(5), 656-660 (2005).
69. Guo DM, Zhang D, Li NM, Zhang L, Yang JH. A novel breath analysis system based on electronic olfaction. IEEE Trans. Biomed. Eng. 57(11), 2753-2763 (2010).
70. Chen HW, Wortmann A, Zhang WH, Zenobi R. Rapid in vivo fingerprinting of nonvolatile compounds in breath by extractive electrospray ionization quadrupole time-of-flight mass spectrometry. Angew. Chem.Int. Ed. 46(4), 580-583 (2007).
71. Garcia-Lopez E, Lindholm B, Davies S. An update on peritoneal dialysis solutions. Nat. Rev.Nephrol. 8(4), 224-233 (2012).
72. Borawski J. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin. Am. J. Kidney Dis. 47(1), 37-41 (2006).
73. Mcintyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease. Blood Purif. 29(2), 105-110 (2010).
74. Capodicasa E, Trovarelli G, De Medio GE et al. Volatile alkanes and increased concentrations of isoprene in exhaled air during hemodialysis. Nephron 82(4), 331-337 (1999).
75. Smith D, Španěl P, Enderby B, Lenney W, Turner C, Davies SJ. Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7-18 years studied using SIFT-MS. J. Breath Res. 4(1), 017101 (2010).
76. Turner C, Španěl P, Smith D. A longitudinal study of breath isoprene in healthy volunteers using selected ion flow tube mass spectrometry (SIFT-MS). Physiol. Meas. 27(1), 13-22 (2006).
77. Diskin AM, Španěl P, Smith D. Time variation of ammonia, acetone, isoprene and ethanol in breath: a quantitative SIFT-MS study over 30 days. Physiol. Meas. 24(1), 107-119 (2003).
78. Lechner M, Moser B, Niederseer D et al. Gender and age specific differences in exhaled isoprene levels. Respir. Physiol. Neurobiol. 154(3), 478-483 (2006).
79. Nelson N, Lagesson V, Nosratabadi AR, Ludvigsson J, Tagesson C. Exhaled isoprene and acetone in newborn infants and in children with diabetes mellitus. Pediatr. Res. 44(3), 363-367 (1998).
80. Zadak Z, Hyspler R, Crhova S, Gasparic J, Cizkova M, Balasova V. Isoprene in expired breath as a marker of cholesterol synthesis for the statin therapy monitoring. Atherosclerosis 144, 206-206 (1999).
81. Jones AW, Lagesson V, Tagesson C. Origins of breath isoprene. J. Clin. Pathol. 48(10), 979-979 (1995).
82. Foster WM, Jiang L, Stetkiewicz PT, Risby TH. Breath isoprene: temporal changes in respiratory output after exposure to ozone. J. Appl. Physiol. 80(2), 706-710 (1996).
83. Smith D, Chippendale TWE, Dryahina K, Spanel P. SIFT-MS analysis of nose-exhaled breath; mouth contamination and the influence of exercise. Curr. Anal. Chem. 9(4), 565-575 (2013).
84. King J, Koc H, Unterkofler K et al. Physiological modeling of isoprene dynamics in exhaled breath. J. Theor. Biol. 267(4), 626-637 (2010).
85. Trovarelli G, Brunori F, De Medio GE et al. Onset, time course, and persistence of increased haemodialysis-induced breath isoprene emission. Nephron 88(1), 44-47 (2001).
86. Capodicasa E, Trovarelli G, Brunori F et al. Lack of isoprene overproduction during peritoneal dialysis. Perit. Dial. Int. 22(1), 48-52 (2002).
87. Capodicasa E, Brunori F, De Medio GE, Pelli MA, Vecchi L, Buoncristiani U. Effect of two-hour daily hemodialysis and sham dialysis on breath isoprene exhalation. Int. J. Artif. Organs 30(7), 583-588 (2007).
88. Lirk P, Bodrogi F, Raifer H, Greiner K, Ulmer H, Rieder J. Elective haemodialysis increases exhaled isoprene. Nephrol. Dial. Transplant. 18(5), 937-941 (2003).
89. Lee HJ, Meinardi S, Pahl MV, Vaziri ND, Blake DR. Exposure to potentially toxic hydrocarbons and halocarbons released from the dialyzer and tubing set during hemodialysis. Am. J. Kidney Dis. 60(4), 609-616 (2012).
90. Goerl T, Kischkel S, Sawacki A, Fuchs P, Miekisch W, Schubert JK. Volatile breath biomarkers for patient monitoring during haemodialysis. J. Breath Res. 7(1), 017116 (2013).
91. Dryahina K, Španěl P, Pospisilova V et al. Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom. 27(17), 1983-1992 (2013).
92. Stevenson KS, Radhakrishnan K, Patterson CS et al. Breath ethane peaks during a single haemodialysis session and is associated with time on dialysis. J. Breath Res. 2(2), 026004 (2008).
93. Rysz J, Kasielski M, Apanasiewicz J et al. Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol. Dial. Transplant. 19(1), 158-163 (2004).
94. Rysz J, Stolarek RA, Luczynski R et al. Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine. Pulm. Pharmacol. Ther. 20(3), 281-289 (2007).
95. Rolla G, Bruno M, Bommarito L et al. Breath analysis in patients with end-stage renal disease: effect of haemodialysis. Eur. J. Clin. Invest. 38(10), 728-733 (2008).
96. Raimann J, Liu L, Ulloa D, Kotanko P, Levin NW. Consequences of overhydration and the need for dry weight assessment. Contrib. Nephrol. 161, 99-107 (2008).
97. Tan BK, Davies SJ, Španěl P, Smith D. Injection of deuterated water into the pulmonary/alveolar circulation; measurement of HDO in exhaled breath and implications to breath analysis. J. Breath Res. 6(3), 036005 (2012).
98. Davies S, Španěl P, Smith D. Rapid measurement of deuterium content of breath following oral ingestion to determine body water. Physiol. Meas. 22(4), 651-659 (2001).
99. Španěl P, Smith D. Selected ion flow tube mass spectrometry (SIFT-MS) and flowing afterglow mass spectrometry (FA-MS) for the determination of the deuterium abundance in water vapour. In:Handbook of Stable Isotope Analytical Techniques . Groot PAD (Ed.). Elsevier, Amsterdam, the Netherlands, 88-102 (2004).
100. Smith D, Španěl P. On-line determination of the deuterium abundance in breath water vapour by flowing afterglow mass spectrometry with applications to measurements of total body water. Rapid Commun. Mass Spectrom. 15(1), 25-32 (2001).
101. Španěl P, Smith D. Accuracy and precision of flowing afterglow mass spectrometry for the determination of the deuterium abundance in the headspace of aqueous liquids and exhaled breath water. Rapid Commun. Mass Spectrom. 15(11), 867-872 (2001).
102. Španěl P, Smith D. Selected ion flow tube mass spectrometry analyses of stable isotopes in water: isotopic composition of H3O+ and H3O+(H2O)(3) ions in exchange reactions with water vapor. J. Am. Soc. Mass Spectrom. 11(10), 866-875 (2000).
103. Španěl P, Shestivska V, Chippendale TWE, Smith D. Determination of the deuterium abundances in water from 156 to 10,000 ppm by SIFT-MS. J. Am. Soc. Mass Spectrom. 22(1), 179-186 (2011).
104. Davies SJ, Engel B, Chan C et al. Breath analysis and the measurement of total body water using isotope dilution - applications in the dialysis clinic. Curr. Anal. Chem. 9(4), 593-599 (2013).
105. Smith D, Engel B, Diskin AM, Španěl P, Davies SJ. Comparative measurements of total body water in healthy volunteers by online breath deuterium measurement and other near-subject methods. Am. J. Clin. Nutr. 76(6), 1295-1301 (2002).
106. Chan C, Mcintyre C, Smith D, Španěl P, Davies SJ. Combining near-subject absolute and relative measures of longitudinal hydration in hemodialysis. Clin. J. Am. Soc. Nephrol. 4(11), 1791-1798 (2009).
107. Smith D, Španěl P, Herbig J, Beauchamp J. Mass spectrometry for real-time quantitative breath analysis. J. Breath Res. In print. (2014).
108. Boshier PR, Cushnir JR, Mistry V et al. On-line, real time monitoring of exhaled trace gases by SIFT-MS in the perioperative setting: a feasibility study. Analyst 136(16), 3233-3237 (2011).
109. Dryahina K, Smith D, Španěl P. Quantification of methane in humid air and exhaled breath using selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom. 24(9), 1296-1304 (2010).
110. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 55(3), 297-303 (2006).
111. Abbott SM, Elder JB, Španěl P, Smith D. Quantification of acetonitrile in exhaled breath and urinary headspace using selected ion flow tube mass spectrometry. Int. J. Mass Spectrom. 228(2-3), 655-665 (2003).
112. Smith D, Španěl P, Gilchrist FJ, Lenney W. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J. Breath Res. 7(4), 044001 (2013).
113. Čáp P, Dryahina K, Pehal F, Španěl P. Selected ion flow tube mass spectrometry of exhaled breath condensate headspace. Rapid Commun. Mass Spectrom. 22(18), 2844-2850 (2008).